Category: bucindolol</em
-
ODonnell (2013) describes this issue as the inability of existing regulatory structures and principles to comply with personalized approaches to medical treatments. Such concerns have arisen in the past
ODonnell (2013) describes this issue as the inability of existing regulatory structures and principles to comply with personalized approaches to medical treatments. Such concerns have arisen in the past 2016). Generally